News Archive
Improved – P242 Pancreatitis – Now Featuring Mutation-Specific Probes for SPINK1 and PRSS1
P242 Pancreatitis just received a major update, with the recently released D1 version featuring nine new target probes and three new mutation-specific probes, as well as three replaced target probes and eight replaced reference probes. The updated probe content facilitates enhanced detection of HP-related genetic alterations and improves assay robustness.
MRC Holland Visiting Scientist to Present on Newborn Screening at International Conferences
Terence Diane Fabella, a PhD candidate and MRC Holland researcher, will present her work on the development of digitalMLPA assays for newborn screening at three international conferences later this year.
Coming Soon - Two New digitalMLPA Assays
Exciting news about our digitalMLPA portfolio – two new digitalMLPA™ assays will be launched soon: NXtec™ D002 Hereditary Cancer Panel 2 and NXtec™ D024 KaryoProfiler!
MCR Holland Prices in 2026
Effective from 1 January 2026, we will be implementing a price increase of 3.6% on average on most of our products.
Our Products are IVDR-Certified!
We have successfully obtained our certification under the new In Vitro Diagnostic Regulation (IVDR; 2017/746)! The first batch of flagship products are already available on the market under the new IVDR, well in advance of the transition period deadline.
Unlocking CNV Certainty: What We Shared at ESHG 2025
We were delighted to attend the 2025 edition of the European Human Genetics Conference in Milan, Italy - read further for our re-cap.
Here Comes the Sun – TERT Promoter Mutations in Skin Lesions
Testing for TERT promoter mutations in certain skin lesions can provide valuable insights - find out which MLPA probemixes can be used to test for these variants.
Documentation Update - digitalMLPA General Protocol
We’ve recently updated the digitalMLPA General Protocol to reflect a new recommendation for read depth - read more about this change.
Introducing NXtec: An Update to digitalMLPA Product Naming
Introducing NXtec—the new product line name for all currently available digitalMLPA assays. This change helps us clearly distinguish our current assays from future variants that may require different protocols or reagents.
Celebrating 40 Years of MRC Holland
This year marks the 40th anniversary of MRC Holland!